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Background: Characteristics of ES cells are 
controlled by gene regulatory networks, and 
ETV4 and -5 participate in the network.  
Results: Proliferation, induction of ectodermal 
marker genes, and expression of stem 
cell-related genes were impaired in Etv4/5 
double KO ES cells 
Conclusion: ETV4 and -5 crucially define 
properties of ES cells. 
Significance: Gene regulatory networks are 
dysregulated in the double KO ES cells. 
 
ABSTRACT 
 The pluripotency and self-renewal 
capacity of embryonic stem (ES) cells is 
regulated by several transcription factors.  
Here, we show that the ETS-related 
transcription factors Etv4 and Etv5 (Etv4/5) 
are specifically expressed in undifferentiated 
ES cells, and suppression of Oct3/4 results in 
down-regulation of Etv4/5.  Simultaneous 
deletion of Etv4 and Etv5 (Etv4/5 double 
knockout, dKO) in ES cells resulted in flat, 
epithelial cell like appearance, while the 
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morphology changed into compact colonies 
in a 2i medium (containing two inhibitors 
for GSK3 and MEK/ERK).  Expression 
levels of self-renewal marker genes, 
including Oct3/4 and Nanog, were similar 
between wild-type and dKO ES cells, 
whereas proliferation of Etv4/5 dKO ES cells 
was decreased with overexpression of 
cyclin-dependent kinase inhibitors (p16/p19, 
p15, and p57).  A differentiation assay 
revealed that the embryoid bodies derived 
from Etv4/5 dKO ES cells were smaller than 
the control, and expression of ectoderm 
marker genes, including Fgf5, Sox1, and 
Pax3, was not induced in dKO derived 
embryiod bodies.  Microarray analysis 
demonstrated that stem cell-related genes, 
including Tcf15, Gbx2, Lrh1, Zic3, and 
Baf60c, were significantly repressed in 
Etv4/5 dKO ES cells.  The artificial 
expression of ETV4 and/or ETV5 in Etv4/5 
dKO ES cells induced re-expression of Tcf15 
and Gbx2.  These results indicate that 
ETV4 and ETV5, potentially through 
regulation of Gbx2 and Tcf15, are involved 
in the ES cell proliferation, and induction of 
differentiation-associated genes in ES cells.  
――――――――――――――――――― 
The self-renewal capacity and 
pluripotency of murine embryonic stem (ES) 
cells is maintained through stimulations of both 
leukemia inhibitory factor (LIF) and bone 
morphogenic protein 4 (BMP4) in vitro (1-3).  
LIF stimulation activates JAK-STAT3 and 
phosphatidylinositol-3-OH kinase (PI3K)-AKT 
pathways and maintains pluripotency of ES 
cells (4). In fact, artificial activation of either 
STAT3 or AKT maintains self-renewal of ES 
cells in the absence of LIF (5,6).  The 
transcription factors KLF4 and TBX3 are 
downstream regulators of STAT3 and AKT, 
respectively, and are involved in the 
maintenance of pluripotency (4).  BMP 
induces expression of the inhibitory of DNA 
binding (Id) genes via the Smad pathway, and 
ID proteins suppress differentiation and sustain 
self-renewal of ES cells in collaboration with 
STAT3 (1).   
In addition to the signal transduction 
pathways, including JAK-STAT, PI3K-AKT, 
and BMP-SMD, several transcription factors, 
including OCT3/4, SOX2, and NANOG, are 
known to be major regulators of self-renewal.  
Oct3/4-deficient embryos develop to the 
blastocyst stage, but their inner cell mass from 
which ES cells are established loses 
pluripotency (7).  A conditional 
Oct3/4-knockout ES cell experiment showed 
that Oct3/4 deficiency promotes differentiation 
of ES cells into extraembryonic 
trophectodermal cells (7,8).  Sox2-deficient 
blastocysts form abnormal inner cell masses 
and fail to undergo outgrowth, and Sox2-null 
ES cells differentiate into trophoblast cells 
(9,10).  Although Nanog-deficient ES cells 
retain the capacity for self-renewal (11), 
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deletion of the Nanog gene causes early 
embryonic lethality, while forced expression of 
Nanog in ES cells accelerates their self-renewal 
in a LIF-independent manner (12,13).  
Furthermore, other transcriptional regulators, 
including ESRRB (14-16), DAX1 (17-19), 
SALL4 (20-22), ZIC3 (23), KLF4 (24), MYC 
(25,26), and MAX (27), have been identified as 
key regulators of the self-renewal capacity and 
pluripotency of ES cells. 
High-throughput analyses revealed that 
these transcription factors form a complex 
network of regulatory and/or feed-forward 
loops in ES cells.  For example, chromatin 
immunoprecipitation experiments showed that 
OCT3/4, NANOG, SOX2, and other ES 
cell-specific transcription factors co-occupy 
target genes in ES cells and participate in 
regulatory loops which maintain self-renewal 
and pluripotency (24,28-33).  Protein-protein 
interaction networks centered on OCT3/4, 
NANOG, and MYC are thought to be involved 
in the maintenance of ES cell characteristics 
(34-37).  Recent studies have shown that ES 
cells and tumor cells often possess similar 
characteristics, including rapid cell 
proliferation, self-renewal capacity in the 
undifferentiated state, and gene expression 
signatures (38,39), indicating that genes 
involved in oncogenesis may also play role(s) 
in the constitution of ES cell characteristics. 
The ETS transcription factors of the 
PEA3 group, including ETV1 (also called 
ER81), ETV4 (also called PEA3), and ETV5 
(also called ERM) are involved in critical 
physiological processes such as early 
development, organogenesis, and 
morphogenesis (40).  ETV4 and ETV5 often 
have similar functions during morphogenesis, 
but ETV1 is thought to be different.  A single 
knockout of either Etv4 or Etv5 is not sufficient 
to cause kidney defects, but Etv4/5 double 
knockout mice do not develop kidneys, 
suggesting that ETV4 and ETV5 are 
functionally redundant (41).  These 
transcription factors also function as 
oncoproteins in several tumor cells and 
promote cell proliferation (42).  Interestingly, 
the BioGPS Database, as well as several 
studies, indicates that Etv4 and Etv5 are 
expressed in ES cells (32,33,43), indicating 
that ETV4 and ETV5 could be involved in the 
self-renewal capacity and/or pluripotency of 
ES cells.  In the present study, we discovered 
that the expression of Etv4 and Etv5 is 
regulated by OCT3/4, and investigations of 
Etv4 and Etv5 double knockout ES cells 
clarified that these two molecules are involved 




Cell culture  
 ES cell lines PE9 (control wild-type 
ES cells), PE15-2 (Etv4 and Etv5 double 
knockout (Etv4/5 dKO) ES cells), and ZHBTc4 
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(conditional Oct3/4-knockout ES cells) are 
derived from previous investigations (8,44).  
These cells were cultured on gelatin coated 
dishes with LIF-supplemented Dulbecco’s 
modified Eagle’s medium (DMEM) as 
described previously (5,45).  For the 2i 
culture, PE9 and PE15-2 ES cells were cultured 
in a chemically defined medium [DMEM/F12 
with N2B27-supplement plus 2i (2 μM 
mitogen-activated protein kinase/extracellular 
signal-regulated kinase (PD0325901) and 3 μM 
glycogen synthase kinase 3 (CHIR99021) 
inhibitors)] (Wako Pure Chemical, Osaka, 
Japan) as described previously (46).  For the 
LIF depletion culture, PE9 and PE15-2 ES cells 
were cultured for 3 days in the absence of LIF 
in gelatin coated dishes.  To control Oct3/4 
expression, ZHBTc4 ES cells were cultured 
with or without 1 μg/mL tetracycline (Tet, 
Sigma-Aldrich, St. Louis, MO) for 24 to 48 h.  
To restore Oct3/4 expression, the culture 
medium of Tet-treated cells was changed to a 
Tet-free medium, and the cells were cultured 
for another 24 h.  For the embryoid body (EB) 
formation assay, ES cells were cultured by a 
hanging drop method (1 x 104 cells/20 μl).  
After 3 days, the EBs were transferred to 
ultra-low attachment tissue culture plates 
(CORNING, Corning, NY) and then cultured 
for 6 to 9 days in the absence of LIF.   
Plasmid construction and transfection  
 Construction of mammalian 
expression vectors pCAGIP-Myc and 
pCAGIP-Flag has been described previously 
(18,47).  A hygromycin resistant pCAG 
vector was constructed by inserting the 
puromycin-resistance gene of pCAGIP-Myc 
into the hygromycin-resistance gene. The 
plasmid was named pCAGIH-Myc.  Coding 
regions of Etv4 and Etv5 were amplified by 
PCR using specific primers listed in Table S1.  
pCAGIP-Myc-Etv4, pCAGIP-Myc-Etv5, 
pCAGIP-Flag-Etv5, and pCAGIH-Myc-Etv4 
were constructed by inserting corresponding 
coding sequences into the expression vectors.  
For reporter plasmids construction, the 
promoter region (from −2019 to −2486, 
transcription start site is considered as +1) of 
the Etv4 gene and the intron 6 region of the 
Etv5 gene were amplified by PCR using 
specific primers listed in Table S1.  To 
introduce mutation of an OCT3/4-binding 
sequence of these regions, mutated OCT3/4 
binding sequences were constructed by PCR 
using specific primers.  PCR products were 
cloned into pGL4-promoter (48) and termed 
pGL4-promoter-Etv4 (−2486/−2019)-wild-type, 
-Etv4 (−2486/−2019)-mutant, -Etv5 intron 
6-wild-type, and -Etv5 intron 6-mutant, 
respectively. 
 Plasmids were introduced into 
cultured cells using lipofectamine 2000 (Life 
Technologies, Grand Island, NY) according to 
the manufacturer's protocol.  ETV4- or 
ETV5-expressing ES cells were established by 
introduction of pCAGIP-Myc-Etv4 or -Etv5 
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into Etv4/5 dKO (PE15-2) ES cells and 
cultured in the presence of 0.5 μg/mL 
puromycin (Nacalai Tesque, Kyoto, Japan).  
ETV4/5-expresssing PE15-2 ES cells were 
established as follows.  First, 
ETV4-expressing PE15-2 ES cells were 
established by introducing pCAGIH-Myc-Etv4 
into PE15-2 ES cells. They were subsequently 
cultured in the presence of 300 μg/mL 
hygromycin (Nacalai Tesque).  After that, 
pCAGIP-Flag-Etv5 was introduced into the 
cells. Cells were selected by puromycin, and 
the cell line was named PE15-2 (ETV4/ETV5) 
#8.  A control cell line was established by 
introduction of empty vectors (both 
pCAGIH-Myc and pCAGIP-Flag) into PE15-2 
ES cells in parallel. The cell line was named 
PE15-2 (ev/ev) #1. 
Biotin-labeled DNA pull-down assay  
 Oligonucleotides containing an 
OCT3/4-binding site of the Etv4 gene and 
ETV4/5-binding site of the Gbx2 gene were 
synthesized.  The oligonucleotide sequences 
are shown in Table S1.  For a biotin-labeled 
DNA pull-down assay, 5 μM of 3′-biotinylated 
double stranded oligonucleotide was incubated 
overnight at 4°C with 1 mg of either 
Myc-Oct3/4-, Myc-Etv4-, or 
Myc-Etv5-transfected HEK293 cell extracts in 
the presence of streptavidin-agarose (EMD 
Millipore, Darmstadt, Germany).  For the 
competition assays, non-labeled 
oligonucleotide, either wild-type or mutant, 
was added in 25-fold molar excess.  The 
beads were washed three times with a washing 
buffer [50 mM Tris-HCl (pH 7.5), 2 mM 
MgCl2, and 150 mM NaCl].  Samples were 
examined by Western blot analysis. 
Immunofluorescent staining, Western blot 
analysis, and determination of alkaline 
phosphatase activity  
 For immunostaining analysis, ES 
cells were fixed with 4% paraformaldehyde at 
4°C for 30 min. After permeabilization with 
0.5% Triton X-100 in phosphate-buffered 
saline (PBS) (-), the cells were preincubated 
with 1% BSA in PBS (-).  The cells were then 
incubated with antibodies against Nanog 
(SC1000, Merck Millipore, Darmstadt, 
Germany), OCT3/4 (sc-9081, Santa Cruz 
Biotechnology, Santa Cruz, CA), or ESRRB 
(PP-H6705-00, Perseus Proteomics, Tokyo, 
Japan) at 4°C overnight, followed by 
incubation with 100-fold diluted goat 
anti-rabbit or anti-mouse IgG FITC  (Santa 
Cruz Biotechnology).  For Western blot 
analysis, samples were mixed with an SDS 
sample buffer [5x buffer; 50 mM Tris-HCl (pH 
6.8), 30% glycerol, 10% SDS, 250 mM 
dithiothreitol, 10 mM EDTA, and 0.01% 
Coomassie brilliant blue R250], subjected to 
SDS-10% polyacrylamide gel electrophoresis 
(PAGE), and transferred to a nitrocellulose 
membrane.  The membrane was incubated 
with antibodies for NANOG, OCT3/4, ESRRB, 
αTUBULIN (M175-3, MBL, Nagoya, Japan), 
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or c-Myc (sc-40; Santa Cruz Biotechnology), 
followed by horseradish peroxidase 
(HRP)-conjugated goat anti-mouse or 
anti-rabbit IgG (EMD Millipore).  The blot 
was visualized using enhanced 
chemiluminescence reagents (PerkinElmer, 
Waltham, MA) with an LAS-1000 image 
analyzer (Fuji Film).  Activity of alkaline 
phosphatase was determined using either a 
quantitative alkaline phosphatase ES 
characterization kit (Merck Millipore) or a 
vector blue substrate kit (Vector Laboratories, 
Inc., Burlingame, CA) according to the 
manufacturer's protocols. 
 For the reporter assay, ZHBTc4 ES 
cells were transfected with pGL4 reporter 
plasmids, and these cells were divided into two 
dishes 24 h after transfection and cultured with 
or without 1 μg/mL Tet for 24 h.  Cells were 
lysed in the cell lysis buffer, and luciferase 
activity in the extracts was measured using a 
luciferase assay kit (Promega, Madison, WI) 
with an AB-2200 (ATTO, Tokyo, Japan). 
Preparation of nuclear extracts and the 
electromobility shift assay   
 Nuclear extracts were isolated as 
described before (16).  Briefly,  ZHBTc4 ES 
cells treated with or without 1 μg/mL Tet for 3 
days were resuspended in a buffer [20 mM 
HEPES (pH 7.9), 20% glycerol, 10 mM NaCl, 
0.2 mM EDTA (pH 8.0), 1.5 mM MgCl2, 1 
mM dithiothreitol (DTT), 10 μg/mL leupeptin, 
10 μg/mL pepstatin, and 10 μg/mL aprotinin].  
Samples were incubated on ice for 15 min and 
spun down at 1,000 rpm for 10 min.  The 
pellet was resuspended in the same buffer at 
2.5×107 nuclei/mL, and then 62.5 μL of 5 M 
NaCl was added to the 1 mL of sample.  After 
incubation at 4°C for 30 min, the sample was 
centrifuged at 10,000 rpm, and the supernatant 
was used as a nuclear extract. 
 Oligonucleotides containing the 
OCT3/4-binding site of the Etv5 gene were 
synthesized.  The oligonucleotide sequences 
are shown in Table S1.  Double-stranded 
probes were end-labeled with [γ-32P] ATP (MP 
Biomedicals, Santa Ana, CA) and purified by 
mini Quick Spin Oligo Columns (Roche 
Diagnostics, Basel, Switzerland).  For a 
binding reaction, 5 μg of nuclear extracts were 
incubated with a radio-labeled probe, 2 μg of 
poly (dIdC), and 300 μg/ml of BSA either with 
or without 200-fold excess of cold probe, either 
wild-type or mutated oligonucleotides, as a 
competitor.  Also, either 2–4 μg anti-OCT3/4 
antibody (sc-5279; Santa Cruz Biotechnology) 
or an anti-Flag antibody (F3165; 
Sigma-Aldrich, St. Louis, MO) were added to 
the reaction mixture for a super-shift assay.  
After incubation on ice for 40 min, the samples 
were subjected to electrophoresis in a 
nondenaturing 6% acrylamide gel at 100 V for 
2 h.  The gel was dried, and radio-labeled 
bands were visualized with an image analyzer 
(BAS-2000, Fuji Film, Tokyo, Japan). 
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Reverse transcription-PCR (RT-PCR), 
quantitative RT-PCR, and oligo DNA 
microarray analysis  
 Total RNAs were isolated from cells 
with Sepasol-RNA I Super G (Nacalai Tesque) 
and converted to cDNAs by ReverTraAce 
(Toyobo, Osaka, Japan) with oligo(dT)12-18 
primers (Nippongene, Tokyo, Japan).  Gene 
expression was determined by either regular 
RT-PCR or quantitative RT-PCR using Sybr 
green (Mx3005P; Agilent Technologies, Santa 
Clara, CA, USA).  For quantitative RT-PCR, 
all samples were tested in triplicate, and the 
results from each sample were normalized 
relative to glyceraldehyde-3-phosphate 
dehydrogenase with the delta-delta Ct methods.  
Primer sequences have been described 
previously (16,49) or are listed in Table S1.  
 The 3D-Gene Mouse Oligo chip 24k 
(Toray Industries Inc., Tokyo, Japan) was used 
for the oligo DNA microarray analysis.  
Briefly, one pair of RNA samples was 
collected from control wild-type and Etv4/5 
dKO ES cells.  Total RNA was labeled with 
either Cy3 or Cy5, and Cy3- or Cy5-signals 
were obtained using the 3D-Gene Scanner 
(Toray Industries Inc.) and processed by 
3D-Gene Extraction (Toray Industries Inc.). 
Detected signals for each gene were 
normalized by a global normalization method 
(Cy3/Cy5 ratio median = 1).  Gene ontology 
term analysis and pathway analysis were done.  
The raw data has been deposited in the Gene 
Expression Omnibus (GEO) database, under 
number GSE47225. 
Cell proliferation assay   
 The number of viable cells was 
measured by a direct cell count and a WST-1 
assay. The WST-1 assay was performed 
according to the manufacturer’s protocol 
(Roche Diagnostics, Basel, Switzerland).  
Briefly, cells were cultured in a 96-well plate 
for 3 days.  Ten microliters of WST-1 reagent 
were added to each well, followed by 
incubation at 37°C.  The absorbance of the 
culture medium was measured at 450 nm and 




Expression of Etv4 and Etv5 mRNA correlates 
with Oct3/4 expression  
 The transcription factor OCT3/4 is 
one of the major regulators of the self-renewal 
of ES cells.  ZHBTc4 ES cells are tetracycline 
(Tet)-inducible Oct3/4-conditional knockout 
ES cells, which differentiate into 
trophectoderm after Oct3/4 depletion (8).  
Here we examined the expression of Etv4 and 
Etv5 mRNA in ZHBTc4 ES cells.  Oct3/4 was 
expressed in ZHBTc4 ES cells in the absence 
of Tet, and the expression was repressed by Tet 
treatment for 3 to 6 days (Figure 1A).  Etv4 
and Etv5, as well as Dax1 which is a direct 
downstream target of OCT3/4 (50), were also 
expressed in control ZHBTc4 ES cells, and 
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their expressions was also repressed after the 
treatment with Tet (Figure 1A), indicating that 
Etv4 and Etv5 are expressed in undifferentiated 
ES cells and that their expression is repressed 
in trophectodermal cells. 
We also examined the effects of 
short-term exposure to Tet on the expression of 
Etv4 and Etv5 in ZHBTc4 ES cells.  Oct3/4 
expression was repressed by Tet treatment 
within 24 h, and its expression was recovered 
by the removal of Tet (Figure 1B).  
Expression of Etv4 and Etv5, as well as Dax1, 
was reduced after treatment with Tet for 24 to 
48 h and recovered by the removal of Tet 
(Figure 1B), showing that expression of Etv4 
and Etv5 mRNA correlates with Oct3/4 
expression in ES cells. 
Next, we investigated whether 
expression of Etv4 and Etv5 is regulated by 
OCT3/4 in ES cells.  The consensus sequence 
of an OCT3/4-binding site is known to be 
ATGCAAAT.  The Etv4 gene contains several 
consensus OCT3/4-binding sequences, and the 
promoter region (from −2486 to −2019, 
transcription start site considered as +1) of the 
gene contains the consensus sequences and had 
enhancer activity in ES cells (Figure 1C).  
The enhanced activity was repressed after Tet 
stimulation (Oct3/4-depletion condition) in 
ZHBTc4 ES cells, and no enhancer activity was 
detected when the consensus sequences were 
mutated (from ATTTGCAT to GACGTGGG).  
An association of the consensus sequences and 
OCT3/4 was observed by a biotin-labeled DNA 
pull-down assay.  Myc-tagged OCT3/4 was 
precipitated with a biotin-labeled 
oligonucleotide contacting the OCT3/4-binding 
site of the Etv4 gene, and the association was 
competed by an excess of unlabeled 
oligonucleotide, but not by unlabeled mutated 
oligonucleotide (Figure 1D). 
Because the intron 5 and intron 6 of 
the Etv5 gene contain the consensus sequences 
for OCT3/4, we also performed a luciferase 
reporter assay and found that the intron 6 
region, but not the intron 5 region, had an 
enhancer activity in ES cells (Figure 1E and 
data not shown).  Similar to the result with the 
Etv4 gene, the enhanced activity was reduced 
after Tet stimulation in ZHBTc4 ES cells.  No 
enhancer activity was detected when the 
consensus sequences were mutated from 
ATGCAAAT to GTGCCGCT.  An 
electrophoresis mobility shift assay (EMSA) 
revealed that the 25 bp oligonucleotide 
containing OCT3/4 binding site of the intron 6 
formed a complex with OCT3/4 in vitro 
(Figure 1F).  The complex was not detected 
when a nuclear extract from Tet-treated 
ZHBTc4 ES cells was examined.  The 
unlabeled competitor (x200) inhibited the 
formation of the complex, but it was not 
competed by an excess of unlabeled mutated 
oligonucleotide.  Also, the band was 
supershifted by an addition of an anti-OCT3/4 
antibody, but not an anti-Flag antibody as a 
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negative control.  These results indicate that 
OCT3/4 binds to the Etv4 and Etv5 gene and 
regulates their expression. 
Etv4 and Etv5 dKO ES cells maintain an 
undifferentiated state  
 ETV4 and ETV5 have similar 
molecular structures and exhibit overlapping 
expression, and redundant activities of ETV4 
and ETV5 have been noted in kidney 
development (41).  Also, RNAi depletion of 
Etv5 in ES cells did not result in obvious 
phenotypes (51).  Thus, we analyzed Etv4/5 
dKO ES cells to explore the functions of ETV4 
and ETV5 in ES cells.   
 One major characteristic of ES cells 
is the capacity for self-renewal; they have the 
potential to proliferate in an undifferentiated 
state.  First, we examined whether Etv4/5 
dKO ES cells maintain an undifferentiated state 
or not.  Control wild-type ES cells (PE9 ES 
cells) formed a compact colony, which is 
typical of undifferentiated ES cells, in the 
presence of LIF. In contrast, Etv4/5 dKO ES 
cells (PE15-2 ES cells) failed to form a 
compact colony, but showed an epithelial 
cell-like morphology even in the presence of 
LIF (Figure 2A).  After removing LIF from 
the culture medium, both control and the dKO 
ES cells showed epithelial cell-like 
morphology.  Expression analysis showed that 
Nanog, Oct3/4, Esrrb, and Dax1 were 
expressed in Etv4/5 dKO ES cells, as well as 
control cells, and downregulated after depletion 
of LIF from culture medium (Figure 2B).  We 
also examined protein expression of 
self-renewal markers, including NANOG, 
OCT3/4, and ESRRB, in Etv4/5 dKO ES cells.  
Immunofluorescent staining and Western blot 
analysis revealed that NANOG, OCT3/4, and 
ESRRB were expressed in Etv4/5 dKO ES 
cells (Figure 2C, D, E, F).  In addition, 
relative alkaline phosphatase activity, which is 
a marker of undifferentiated pluripotent stem 
cells, was comparable between wild-type and 
Etv4/5 dKO ES cells (Figure 2G, H).  
 Self-renewal capacity is maintained 
by LIF stimulation followed by STAT3 
activation.  A recent study showed that 
inhibition of GSK3 and MEK/ERK pathways 
by small molecule inhibitors (2i) achieves 
LIF/STAT3-independent self-renewal of ES 
cells without serum (46), and naive ES cells 
can be cultured in the 2i medium, whereas 
primed epiblast stem cells cannot (52).  Here, 
we examined whether Etv4/5 dKO ES cells can 
be cultured in the 2i medium.  As shown in 
Figure 3A, PE9 wild-type and PE15-2 Etv4/5 
dKO ES cells grew in the 2i medium, and the 
epithelial-like morphology of PE15-2 ES cells 
was changed into a compact colony in the 2i 
medium.  In PE9 wild-type ES cells, 
expression of Etv5 mRNA was maintained in 
the 2i medium, however, Etv4 mRNA was 
drastically repressed, suggesting that ETV4 is 
dispensable for the native status of ES cells.  
Quantitative RT-PCR analysis demonstrated 
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that undifferentiated marker genes (Oct3/4, 
Nanog, and Esrrb), as well as naive marker 
genes (Dax1 and Rex1) were expressed in PE9 
and PE15-2 ES cells in the 2i medium (Figure 
3C), suggesting that Etv4/5 dKO ES cells are 
able to maintain their naive status.  Taken 
together, these results suggest that ETV4 and 
ETV5 are dispensable for the maintenance of 
the undifferentiated state of ES cells.   
ETV4 and ETV5 regulate proliferation of ES 
cells  
 After finding that Etv4/5 dKO ES 
cells expressed self-renewal marker genes, next 
we compared the proliferation of control 
wild-type and Etv4/5 dKO ES cells.  A WST-1 
assay demonstrated that cell proliferation was 
reduced in Etv4/5 dKO ES cells (Figure 4A).  
Direct cell counting also showed that 
proliferation of Etv4/5 dKO ES cells was 
significantly decreased compared with 
wild-type ES cells (Figure 4B).  We also 
compared cell counts between wild-type and 
Etv4/5 dKO ES cell cultured in the 2i medium.  
As shown in Figure 4C, proliferation of Etv4/5 
dKO ES cells is slower than wild-type ES cells, 
indicating that proliferation of the dKO ES 
cells is not recovered even in the 2i condition. 
Of note, expression of cyclin-dependent kinase 
inhibitors, including p16-INK4/p19-ARF, p15 
and p57, was completely repressed in wild-type 
ES cells. By contrast, their expression was 
enhanced in Etv4/5 dKO ES cells (Figure 4D).  
These results demonstrate that ETV4 and 
ETV5 regulate the proliferation of ES cells by 
controlling cyclin-dependent kinase inhibitors. 
Etv4/5 dKO ES cells are impaired in ectoderm 
marker gene induction  
 Next, we assessed differentiation 
ability, the second characteristic of ES cells, in 
Etv4/5 dKO ES cells within a system of EBs in 
suspension culture, which mimics early 
embryogenesis in vitro.  Control wild-type ES 
cells formed EBs normally, whereas the EBs 
derived from Etv4/5 dKO ES cells were much 
smaller than control cells (Figure 5A).  
Quantitative RT-PCR analysis revealed that 
expression of endoderm (Gata4 and Gata6) 
and mesoderm (Flk1, T, and Tbx5) markers 
was very similar between PE9 and PE15-2 
cells (Figure 5B).  In contrast, expression 
patterns of ectoderm markers (Fgf5, Sox1, and 
Pax3) differed.  Fgf5 expression was induced 
in an EB sample that had been incubated for 3 
days and it was repressed immediately in PE9 
ES cells, whereas, its expression was not 
induced in PE15-2 ES cells.  Strong 
expression of Sox1 and Pax3 was found in an 
EB sample of PE9 ES cells that had been 
incubated for 9 days, but they were not induced 
in PE15-2 cells.  These results suggest that 
Etv4/5 dKO ES cells have an impaired ability 
to induce ectoderm marker gene expression in 
vitro. 
Gene expression signatures of Etv4/5 dKO ES 
cells  
 Recent studies indicate that gene 
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regulatory and/or transcription factor networks 
are involved in determining the characteristics 
of ES cells.  Since Etv4/5 dKO ES cells 
showed reduced proliferation and an impaired 
ability to induce an ectoderm marker, it is 
possible that the networks are changed in part.  
We compared the transcriptional profiles of 
wild-type and Etv4/5 dKO ES cells using 
oligonucleotide-based DNA microarray 
analysis.  Pathway analysis showed that 
several pathways were significantly changed 
(Supplemental Table S2).  Furthermore, gene 
ontology (GO) term analysis revealed that 
genes involved in metabolic process, regulation 
of transcription DNA-dependent, translation 
elongation, transcription DNA-dependent, and 
lipid biosynthetic were down-regulated in 
Etv4/5 dKO ES cells (Figure 6A).  Of note, 
gene expression-related GO terms (regulation 
of transcription DNA-dependent, translation 
elongation, and transcription DNA-dependent) 
were enriched.  Genes with the GO term 
regulation of transcription DNA-dependent, are 
listed in Table 1.  Several stem cell-related 
transcription factors, including Tcf15, 
Lrh1/Nr5a2, Gbx2, Baf60c/Smarcd3, and Zic3, 
were repressed in Etv4/5 dKO ES cells.  
Reduced expression of these genes in Etv4/5 
dKO ES cells was validated by quantitative 
RT-PCR (Figure 6B), indicating that the 
transcriptional network is impaired in Etv4/5 
dKO ES cells.  We also examined the 
expression of these genes in the 2i medium.  
In wild-type ES cells, expression of Tcf15, 
Gbx2 and Baf60c was repressed, whereas, Zic3 
and Lrh1 were unchanged, indicating that Tcf15, 
Gbx2, and Baf60c are dispensable for the 
native status of ES cells (Figure 6C).  In 
Etv4/5 dKO ES cells, the expression of these 
genes was still repressed compared to 
wild-type ES cells, suggesting that repressed 
genes in the dKO ES cells are not recovered by 
2i medium. 
Both ETV4 and ETV5 are able to rescue the 
epithelial like morphology and expression of 
Tcf15 and Gbx2 in dKO ES cells Next, we 
established ETV4/5-expressing PE15-2 ES 
cells, where exogenous ETV4 and ETV5 were 
stably expressed in Etv4/5 dKO ES cells.  As 
shown in Figure 7A, artificial expression of 
ETV4 and ETV5 in the dKO ES cells resulted 
in compact colony formation, in contrast to the 
control cells, which remained flat in shape.  
When we examined gene expression in these 
cells, expression of Tcf15 and Gbx2, which are 
known to regulate ES cell-characteristics (see 
the Discussion section), was recovered in the 
ETV4/5-expressing PE15-2 ES cells (Figure 
7B). 
 Since redundant activities of ETV4 
and ETV5 have been reported, we examined 
whether single overexpression of either ETV4 
or ETV5 in PE15-2 ES cells is enough to 
recover the morphology and gene expression of 
Tcf15 and Gbx2.  Etv4/5 dKO ES cells were 
transfected with either an ETV4 or ETV5 
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expression vector and the expression of the 
dysregulated genes in Etv4/5 dKO ES cells was 
examined.  As shown in Figure 7C, single 
overexpression of either ETV4 or ETV5 in 
dKO ES cells resulted in the cells forming a 
compact colony.  Also, expression of Tcf15 
and Gbx2 was recovered in these cells (Figure 
7D).  The Gbx2 promoter contains the 
ETV4/5 binding site (from −1283 to −1266, 
transcription start site considered as +1).  An 
association of the consensus sequences and 
either ETV4 or ETV5 was observed by a 
biotin-labeled DNA pull-down assay.  Either 
myc-tagged ETV4 or myc-tagged ETV5 was 
precipitated with a biotin-labeled 
oligonucleotide contacting the ETV4/5-binding 
site of the Gbx2 gene, and the association was 
competed by an excess of unlabeled 
oligonucleotide, but not by unlabeled mutated 
oligonucleotide (Figure 7E).  Taken together, 
these results suggest that the morphological 
phenotype of Etv4/5 dKO ES cells is rescued 
by either ETV4 or ETV5, and Gbx2 could be a 




 ETV4 and ETV5 play crucial roles 
during organogenesis and morphogenesis.  
ETV4 is important for neuronal development, 
evidenced by the fact that Etv4 deficient mice 
have defects in neuromuscular innervation (53).  
Also, Etv4 deficient male mice fail to 
reproduce, likely because of dysfunctions in 
erection or ejaculation (54).  Phenotypes of 
Etv5 deficient mice vary depending on the gene 
targeting constructions.  Mice homozygous 
for a deletion of exons 2 to 5 of the Etv5 gene 
are viable, but display disruptions of 
spermatogenesis in males and functional 
disorders of the ovary in females (55,56).  A 
much more severe phenotype occurs when 
exons 11 and 12 of the Etv5 gene are deleted 
(the same as our Etv4/5 dKO ES cell construct). 
In that case, the homozygotes are embryonic 
lethal at E8.5 (41).  In addition, ETV4 and 
ETV5 have essential functions for kidney 
development.  A single knockout of either the 
Etv4 or Etv5 gene had little effect on mouse 
kidney development, whereas kidney 
development failed completely in Etv4/5 dKO 
mice (41,44).  Since our results show that 
expression patterns of ectoderm markers differ 
between wild-type and dKO ES cells in an EB 
assay, ETV4 and ETV5 are likely involved in 
early embryogenesis, as well as organogenesis.   
Etv4 and Etv5 are downstream targets 
of GDNF/RET signaling in kidney 
development (41,44) and FGF signaling in 
limb development (57).  Here, we show that 
Etv4 and Etv5 are expressed in undifferentiated 
ES cells, and that their expression is 
down-regulated after repression of Oct3/4.  
Since OCT3/4 is the major transcription factor 
in ES cells, it seems reasonable to suggest that 
ETV4/5 is involved in the stemness of ES cells.  
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In fact, although Etv4/5 dKO ES cells 
expressed self-renewal marker genes, including 
Oct3/4 and Nanog, the cells failed to form a 
compact colony, which is typical of 
undifferentiated ES cells.  Furthermore, 
reduction of Nanog, Esrrb, and Dax1 in Etv4/5 
dKO was mild at -LIF 3 days (Figure 2B), and 
expression of Oct3/4 and Nanog increased in 
Etv4/5 dKO ES cells cultured with 2i condition 
(Figure 3C). Molecular mechanisms of the 
phenotype remain to be clarified.  Of note, the 
expression of several stem cell-related genes 
(Tcf15, Lrh1/Nr5a2, Gbx2, Baf60c/Smarcd3, 
and Zic3) was repressed, whereas the 
expression of differentiation-associated genes 
(Olig1, Olig2, Gata2, and Hand1) was 
enhanced in the cells from microarray analysis 
(data not shown).  The self-renewal capacity 
and pluripotency of ES cells is thought to be 
controlled by gene regulatory networks, of 
which OCT3/4 and NANOG serve as master 
regulators.  ETV5 is one of a large number of 
additional transcription factors in the network 
(33).  Our investigation revealed that ETV4/5 
are dispensable for self-renewal ability. 
However, induction of ectodermal gene 
expression was impaired in Etv4/5 dKO ES 
cells.  Therefore, we conclude that Etv4/5 
dKO ES cells are not completely differentiated 
and instead remain between an undifferentiated 
and a differentiated state or prodifferentiated 
state.  Alternatively, since ES cells are 
thought to be a heterogeneous population, the 
Etv4/5 dKO ES cell line may represent a mixed 
population of undifferentiated and 
differentiated cells. 
 Overexpression of both ETV4 and 
ETV5, as well as single overexpression of 
either ETV4 or ETV5, in dKO ES cells led to 
morphological changes (formation into a 
compact colony) and re-induction of Tcf15 and 
Gbx2 expression, suggesting a redundant 
function of ETV4 and ETV5 in ES cells.  The 
proliferation ratio was almost comparable 
between ETV4/5-expressing dKO ES cells and 
empty vectors transfected dKO ES cells (data 
not shown).  Since the expression of 
exogenous Etv4 and Etv5 was driven by the 
CAG promoter, a strict regulation by their 
native promoters may be required for complete 
rescue of phenotype of dKO ES cells.   
 Our analysis indicates that Tcf15 and 
Gbx2 are target genes of ETV4 and ETV5.  
TCF15 is a basic helix-loop-helix transcription 
factor and thought to be a key regulator of 
mesoderm differentiation (58). Furthermore, 
somite formation is disrupted in Tcf15 deficient 
mice (59).  TCF15 primes pluripotent cells for 
entry to the somatic lineage, and forced 
expression of TCF15 in ES cells suppresses 
endodermal differentiation (60).  Gbx2 is a 
homeobox gene and downstream target of 
LIF/STAT3 in ES cells (61).  GBX2 
overexpressing ES cells are able to maintain 
the undifferentiated state in the absence of LIF.  
Stat3-deficient ES cells differentiate even in 
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the presence of LIF, although the cells are able 
to maintain the undifferentiated state by 
treatment with 2i  (46).  Importantly, GBX2 
suffices to maintain the undifferentiated state in 
Stat3-deficient ES cells without 2i, suggesting 
that GBX2 is a regulator of ES cell 
self-renewal.  Although Tcf15 and Gbx2 are 
downstream genes of ETV4 and ETV5 and 
could be involved in determining ES cell 
properties, these two molecules were 
insufficient to rescue the phenotypes of Etv4/5 
dKO ES cells.  We also overexpressed GBX2 
in Etv4/5 dKO ES cells, but it appeared to have 
cytotoxic activity and thus ES cell colonies 
were not obtained (data not shown).  
Overexpression of TCF15 in Etv4/5 dKO ES 
cells led to compact colony formation, but cell 
proliferation, as well as expression of other 
repressed genes including Zic3 and Gbx2, were 
not recovered (data not shown).  Therefore, 
the compensatory factors for ETV4 and ETV5 
remain to be clarified. 
 ETV4 and ETV5 are overexpressed in 
various tumors, including those affecting the 
breast, ovary, endometrium, prostate and 
esophagus, and are involved in prognosis 
(40,42).  Ectopic forced expression of ETV4 
in breast cancer cells promotes proliferation of 
MDA 231 breast cancer cells with induction of 
cyclin D3 expression (62), and functional 
inhibition of ETV4 or ETV5 by RNAi in 
mouse mammary tumor cells reduces cell 
proliferation with decreased expression of 
cyclin D1 and D2 (63).  Proliferation of 
oesophageal adenocarcinoma cells is also 
regulated by ETV4 (64).  Our present data 
show reduced proliferation of Etv4/5 dKO ES 
cells.  Expression levels of D-type and E-type 
cyclins were comparable between wild-type 
and Etv4/5 dKO ES cells from the microarray 
analysis, however, expression of p16/p19, p15, 
and p57 was significantly enhanced in Etv4/5 
dKO ES cells.  Indeed, ectopic expression of 
either P15 or P16 in human ES cells resulted in 
an accumulation of cells in the G1 phase (65).  
Although the regulation mechanisms of 
p16/p19, p15, and p57 by ETV4 and ETV5 
remain to be elucidated, ETV4 and ETV5 can 
be involved in the proliferation of various types 
of cells by controlling cell cycle regulators.   
 In summary, Etv4/5 dKO ES cells 
express OCT3/4 and NANOG, which are core 
factors of the gene regulatory network, 
allowing their undifferentiated status to be 
maintained.  In contrast, expression of some 
stem cell-related genes, including Tcf15, Gbx2, 
Zic3, and Lrh1, was dysregulated in Etv4/5 
dKO ES cells, indicating that the network of 
the cells is partially impaired resulting in a 
reduction of proliferation and a lack of 
induction of ectodermal gene expression.  
Further studies, including clarification of 
protein interaction partners and 
characterization of downstream targets of 
ETV4/5, will be helpful for understanding the 
functions of ETV4/5 in mouse ES cells. 
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Figure 1.  Expression of Etv4 and Etv5 mRNA in ZHBTc4 ES cells.  (A) Reduction of Etv4 and 
Etv5 mRNA expression after repression of Oct3/4 expression.  ZHBTc4 ES cells were cultured 
with or without 1 μg/mL tetracycline (Tet) for 3 or 6 days.  Expression of the indicated genes was 
examined by RT-PCR.  (B) Induction of Etv4 and Etv5 mRNA expression by Oct3/4 expression.  
ZHBTc4 ES cells were cultured with or without 1 μg/mL Tet for 24 to 48 h.  To restore Oct3/4 
expression, the culture medium of Tet-treated cells was changed to a Tet-free medium, and the cells 
were cultured for another 24 h.  Dax1 was used for a positive control as an OCT3/4 target gene.  
Gapdh was used as an internal control.  All results are representative of three independent 
experiments.  (C) Determination of an OCT3/4-responsive element in the Etv4 gene by a luciferase 
assay.  The promoter region of the Etv4 gene contains a consensus sequence for an OCT3/4 
binding site (ATTTGCAT).  ZHBTc4 ES cells were transfected with either pGL4-promoter 
(control), pGL4-promoter-Etv4 (−2486/−2019)-wild-type (−2486/−2019 WT), or 
pGL4-promoter-Etv4 (−2486/−2019)-mutant (−2486/−2019 Mu).  ZHBTc4 ES cells were divided 
into two dishes 24 h after transfection and cultured with (+) or without (-) 1 μg/mL Tet for 24 h, and 
luciferase activity was measured.  The sequence of the OCT3/4-responsive element was changed 
from ATTTGCAT to GACGTGGG.  The bars represent the means and standard deviations of 
triplicate assays.  (D) OCT3/4 directly binds to the putative binding sequences.  The association 
of DNA and OCT3/4 was examined by a biotin-labeled DNA pull-down assay.  Biotin-labeled 
oligonucleotide containing the putative binding site was incubated with cell extracts from 
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Myc-Oct3/4-transfected HEK293 cells either with or without 25-fold non-labeled wild-type (WT) 
or mutated (Mu) oligonucleotide.  The result shown is representative of three separate experiments.  
(E) Determination of an OCT3/4-responsive element in the Etv5 gene by a luciferase assay.  The 
intron 6 region of the Etv5 gene contains the consensus sequence of an OCT3/4 binding site 
(ATGCAAAT).  ZHBTc4 ES cells were transfected with either pGL4-promoter (control), 
pGL4-promoter-Etv5 intron 6-wild-type (Intron 6 WT), or pGL4-promoter-Etv5 intron 6-mutant 
(Intron 6 Mu).  ZHBTc4 ES cells were divided into two dishes 24 h after transfection and cultured 
with (+) or without (-) 1 μg/mL Tet for 24 h, and luciferase activity was measured.  The sequence 
of the OCT3/4-responsive element was changed from ATGCAAAT to GTGCCGCT.  The bars 
represent the means and standard deviations of triplicate assays.  (F) OCT3/4 directly binds to the 
putative binding sequences.  An association of DNA and OCT3/4 was examined by an EMSA 
assay.  Radio-labeled oligonucleotide containing the putative binding site was incubated with 
nuclear extracts from ZHBTc4 ES cells either with or without 200-fold cold wild-type (WT), cold 
mutated (Mu) oligonucleotides, an anti-OCT3/4 antibody, or an anti-Flag antibody.  The result 
shown is representative of three separate experiments.  Note, a band of OCT1-DNA complex can 
be detected in this assay as described before (66).  
 
Figure 2.  Etv4/5 double-knockout (dKO) ES cells express self-renewal marker genes.  (A) 
Morphological signatures of PE9 (wild-type, WT) and PE15-2 (Etv4/5 dKO) ES cells.  PE9 and 
PE15-2 ES cells were cultured in the presence or absence of LIF for 3 days.  Morphological 
signatures were observed.  (B) Expression of self-renewal marker genes in PE9 and PE15-2 ES 
cells.  Expression of the indicated self-renewal marker genes in the conditions of panel (A) in PE9 
and PE15-2 ES cells was examined by quantitative RT-PCR.  Expression of Etv4 and Etv5 mRNA 
was only shown in PE9 ES cells.  All samples were analyzed in triplicate, and the data were 
normalized to Gapdh expression.  (C-E) Immunofluorescent stain in PE9 and PE15-2 ES cells.  
Protein expression of the self-renewal marker genes, including NANOG (C), OCT3/4 (D), and 
ESRRB (E), in PE9 and PE15-2 ES cells was examined by immunofluorescent stain.  Nuclei were 
stained with the Hoechst stain.  (F) Western blot analysis in PE9 and PE15-2 ES cells.  Protein 
expression of the self-renewal marker genes (NANOG, OCT3/4, and ESRRB) was examined by 
Western blot analysis.  αTUBULIN was used as a loading control.  (G) Determination of alkaline 
phosphatase activity.  Relative activity of alkaline phosphatase was determined in PE9 and PE15-2 
ES cells.  The bars represent the means and standard deviations of triplicate plates.  (H) Alkaline 
phosphatase stain in PE9 and PE15-2 ES cells.  Alkaline phosphatase of ES cells was detected by 
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VECTOR Blue Alkaline Phosphatase Substrate Kit.  Morphological signatures were observed.  
All results are representative of several independent experiments. 
 
Figure 3.  Etv4/5 double-knockout (dKO) ES cells maintain the undifferentiated state in N2B27 
serum free medium plus two inhibitors.  (A) Morphological signatures of PE9 (wild-type, WT) and 
PE15-2 (Etv4/5 dKO) ES cells.  PE9 and PE15-2 ES cells were cultured in either a regular serum- 
and LIF-containing medium or a chemically defined medium [DMEM/F12 with N2B27-supplement 
plus 2i (mitogen-activated protein kinase/extracellular signal-regulated kinase (PD0325901) and 
glycogen synthase kinase 3 (CHIR99021) inhibitors) (2i condition)].  Morphological signatures 
were observed.  (B) Expression of Etv4 and Etv5 in the 2i condition.  Expression of Etv4 and 
Etv5 in the conditions of panel (A) in PE9 and PE15-2 ES cells was examined by quantitative 
RT-PCR.  (C) Expression of self-renewal marker genes in PE9 and PE15-2 ES cells.  Expression 
of the indicated self-renewal marker genes in the conditions of panel (A) in PE9 and PE15-2 ES 
cells was examined by quantitative RT-PCR.  All samples were analyzed in triplicate, and the data 
were normalized to Gapdh expression.  
 
Figure 4.  ETV4 and ETV5 are involved in the proliferation of ES cells.  (A) Proliferation of PE9 
(wild-type, WT) and PE15-2 (Etv4/5 dKO) ES cells.  Either PE9 or PE15-2 ES cells were seeded 
at 500, 1000, or 2000 cells per well in a 96-well dish, and subjected to a WST-1 assay.  The results 
represent the means and standard deviations of triplicate assays.  (B) Growth curves of PE9 and 
PE15-2 ES cells.  PE9 and PE15-2 ES cells were cultured in the presence of LIF, and the number 
of cells was counted at the indicated days.  The results represent the means and standard deviations 
of four independent assays.  (C) Direct cell counts of PE9 and PE15-2 ES cells in the 2i condition.  
PE9 and PE15-2 ES cells were cultured in the 2i condition, and the number of cells was counted at 
the indicated days.  The result represents the means and standard deviations of triplicate 
experiments.  (D) Enhanced expression of cyclin-dependent kinase inhibitors in Etv4/5 dKO ES 
cells.  Expression of cyclin-dependent kinase inhibitors, p16/p19, p15, and p57 mRNA in PE9 and 
PE15-2 ES cells was examined by RT-PCR.  Gapdh was used as an internal control.  The results 
are representative of three independent experiments. 
 
Figure 5.  Etv4/5 double-knockout (dKO) ES cells have impaired abilities to induce ectoderm 
marker gene expression.  (A) Morphological signatures of embryoid bodies (EBs) derived from 
PE9 (wild-type, WT) and PE15-2 (Etv4/5 dKO) ES cells.  PE9 and PE15-2 ES cells were cultured 
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in suspension without LIF for 3–9 days.  Morphological signatures were observed.  Scale bar = 
100 μm. (B) Expression of differentiation marker genes in PE9 and PE15-2 EBs.  Expression of 
the indicated differentiation marker genes in the conditions of panel (A) in PE9 and PE15-2 EBs 
was examined by quantitative RT-PCR.  Expression of Etv4 and Etv5 mRNA was only shown in 
PE9 ES cells.  All samples were analyzed in triplicate, and the data were normalized to Gapdh 
expression. 
 
Figure 6. Several transcription factors are downregulated in Etv4/5 dKO ES cells.  (A) Gene 
ontology (GO) term analysis of downregulated candidates in Etv4/5 dKO ES cells.  Genes 
involved in metabolic process, regulation of transcription DNA-dependent, translation elongation, 
transcription DNA-dependent, and lipid biosynthetic are enriched significantly.  GO categories are 
ranked according to their p-value.  (B)  Expression of several transcription-related genes in PE9 
and PE15-2 ES cells.  Expression of transcription-related genes including Tcf15, Gbx2, Lrh1, Zic3, 
and Baf60c are downregulated in PE15-2 ES cells as shown by microarray analysis.  Expression of 
the indicated genes in PE9 and PE15-2 ES cells was examined by quantitative RT-PCR.  (C) 
Expression of several transcription-related genes in PE9 and PE15-2 ES cells in the 2i condition.  
PE9 and PE15-2 ES cells were cultured in the 2i condition, and expression of the indicated genes 
was examined by quantitative RT-PCR.  All samples were analyzed in triplicate, and the data were 
normalized to Gapdh expression. 
 
Figure 7.  Both ETV4 and ETV5 are able to rescue the epithelial like morphology and expression 
of Tcf15 and Gbx2 in dKO ES cells.  (A) Overexpression of both ETV4 and ETV5 in PE15-2 
(Etv4/5 dKO) ES cells.  ETV4/5-expressing PE15-2 ES cells and control cells were established as 
described in the Materials and Methods section.  Morphological signatures were observed.  Scale 
bar = 50 μm.  (B) Induction of Tcf15 and Gbx2 expression in ETV4/5-expressing PE15-2 ES cells.   
Expression of Tcf15 and Gbx2 mRNA, as well as Lrh1, Zic3, and Baf60c mRNA, in the PE15-2 ES 
cell lines was examined by quantitative RT-PCR.  All samples were analyzed in triplicate, and the 
data were normalized to Gapdh expression.  Expression of Etv4 and Etv5 mRNA was examined by 
regular RT-PCR.  (C) Overexpression of either ETV4 or ETV5 in PE15-2 (Etv4/5 dKO) ES cells.  
ETV4- or ETV5-expressing PE15-2 ES cells and control cells were established as described in the 
Materials and Methods section.  Morphological signatures were observed.  Scale bar = 100 μm.  
(D)  Induction of Tcf15 and Gbx2 expression in ETV4- and ETV5-expressing PE15-2 ES cells.   
Expression of Tcf15 and Gbx2 mRNA, as well as Lrh1, Zic3, and Baf60c mRNA, in the PE15-2 ES 
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cell lines was examined by quantitative RT-PCR.  All samples were analyzed in triplicate, and the 
data were normalized to Gapdh expression.  Expression of Etv4 and Etv5 mRNA was examined by 
regular RT-PCR.  (E) ETV4 and ETV5 directly bind to the putative binding sequences of the Gbx2 
gene.  Biotin-labeled oligonucleotide containing the putative binding site was incubated with cell 
extracts from Myc-ETV4- or Myc-ETV5-transfected HEK293 cells either with or without 25-fold 
non-labeled wild-type (WT) or mutated (Mu) oligonucleotide.  The result shown is representative 
of three separate experiments.   
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Table 1.  Down-regulated genes (GO:0006355; regulation of transcription, DNA-dependent) in 




Zfp386 zinc finger protein 386 (Kruppel-like) -4.02  
Tcf15 transcription factor 15 -3.64  
Trps1 trichorhinophalangeal syndrome I (human) -3.34  
Lrh1/Nr5a2 
nuclear receptor subfamily 5, group A, member 
2 
-3.31  
Gbx2 gastrulation brain homeobox 2 -3.29  
Bcl11a B-cell CLL/lymphoma 11A (zinc finger protein) -2.98  
Nkx6-3 




SWI/SNF related, matrix associated, actin 
dependent regulator of chromatin, subfamily d, 
member 3 
-2.58  
Dbp D site albumin promoter binding protein -2.51  
Rhox10 - -2.43  
Tcea3 transcription elongation factor A (SII), 3 -2.42  
Suhw3 




NK6 transcription factor related, locus 2 
(Drosophila)  
-2.21  
Zic3 zinc finger protein of the cerebellum 3  -2.19  
Zfp459 zinc finger protein 459 -2.11  
A930001N09Rik RIKEN cDNA A930001N09 gene  -2.04  
Spic Spi-C transcription factor (Spi-1/PU.1 related)  -2.03  
Supt16h suppressor of Ty 16 homolog (S. cerevisiae)  -2.01  
Genes, whose expression difference is Log2 [ratio (PE15-2/PE9)] < -2.0, are listed.  Note, dKO 
indicates double knockout. 
Figure 1 
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